Lichen planopilaris: Update on pathogenesis and treatment

SKINmed

Volumn 11, Issue 3, 2013, Pages 161-165

  Baibergenova, Akerke ^a   Donovan, Jeff ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Cleveland Clinic Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

BIOPSY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HAIR; HUMAN; LICHEN PLANUS; PATHOLOGY; REVIEW; SKIN DISEASE; TRANSPLANTATION;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GLUCOCORTICOIDS; HAIR; HUMANS; LICHEN PLANUS; SCALP DERMATOSES;

EID: 84885162812     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009; 28:3–10.
2. Kubba R, Rook A. Graham Little syndrome: follicular keratosis with cicatricial alopecia. Br J Dermatol. 1975;93(suppl 11):53.
3. Zinkernagel MS, Trueb RM. Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern? Arch Dermatol. 2000;136: 205–211.
4. Olsen EA. Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective. J Investig Dermatol Symp Proc. 2005;10:217–221.
5. Ochoa BE, King LE Jr., Price VH. Lichen planopilaris: annual incidence in four hair referral centers in the United States. J Am Acad Dermatol. 2008;58:352–353.
6. Cevasco NC, Bergfeld WF, Remzi BK, et al. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007;57:47–53
7. Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992;27(6 pt 1):935–942.
8. Chew AL, Bashir SJ, Wain EM, et al. Expanding the spectrum of frontal fibrosing alopecia: a unifying concept. J Am Acad Dermatol. 2010;63:653–660.
9. Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol. 2006;126:1459–1468.
10. Meyer KC, Klatte JE, Dinh HV, et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol. 2008;159:1077–1085.
11. Harries MJ, Meyer KC, Chaudhry IH, et al. Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? Clin Exp Dermatol. 2010;35:637–644.
12. Al-Zaid T, Vanderweil S, Zembowicz A, Lyle S. Sebaceous gland loss and inflammation in scarring alopecia: a potential role in pathogenesis. J Am Acad Dermatol. 2011;65:597–603.
13. Stenn KS. Insights from the asebia mouse: a molecular sebaceous gland defect leading to cicatricial alopecia. J Cutan Pathol. 2001;28:445–447.
14. Karnik P, Tekeste Z, McCormick TS, et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol. 2009;129:1243–1257.
15. Harries MJ, Paus R. Scarring alopecia and the PPARgamma connection. J Invest Dermatol. 2009;129:1066–1070.
16. Olsen EA, Bergfeld WF, Cotsarelis G, et al. Summary of the North American Hair Research Society (NAHRS)- sponsored workshop on cicatricial alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol. 2003;48:103–110.
17. Tandon YK, Somani N, Cevasco NC, Bergfeld WF. A histologic review of 27 patients with lichen planopilaris. J Am Acad Dermatol. 2008;59:91–98.
18. Poblet E, Jiménez F, Pascual A, Piqué E. Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study. Int J Dermatol. 2006;45:375–380.
19. Atkins D, Best D, Briss PA, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
20. Chiang C, Sah D, Cho BK, et al. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62:387–392.
21. Sperling LC, Nguyen JV. Commentary: treatment of lichen planopilaris: some progress, but a long way to go. J Am Acad Dermatol. 2010;62:398–401.
22. Mirmirani P, Karnik P. Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol. 2009;145:1363–1366.
23. Baibergenova A, Walsh S. Use of pioglitazone in patients with lichen planopilaris. 22nd World Congress of Dermatology. Abstract FP2011-00987
24. Cribier B, Frances C, Chosidow O. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134:1521–1530.
25. Harries MJ, Sinclair RD, Macdonald-Hull S, et al. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol. 2008;159:1–22.
26. Tosti A, Piraccini BM, Iorizzo M, et al. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol. 2005; 52:55–60.
27. Georgala S, Katoulis AC, Befon A, et al. Treatment of postmenopausal frontal fibrosing alopecia with oral dutasteride. J Am Acad Dermatol. 2009;61:157–158.
28. Katoulis A, Georgala, Bozi E., et al. Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus. J Eur Acad Dermatol Venereol. 2009;23:580–582.
29. Chieregato C, Zini A, Barba A, et al. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003;42:342–345.
30. Cho BK, Sah D, Chwalek J, et al. Efficacy and safety of mycophenolate mofetil for lichen planopilaris. J Am Acad Dermatol. 2010;62:393–397.
31. Reygagne P, Assouly P, Matard B, et al. Oral ciclosporin in lichen planopilaris. Dermatology. 2006;213:59